Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M145Revenue (TTM) $M18.4Net Margin (%)-113.9Altman Z-Score-75.8
Enterprise Value $M205EPS (TTM) $-0.1Operating Margin %-54.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-9.4Pre-tax Margin (%)-120.4Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.1Cash flow > EarningsY
Price/Sales7.85-y EBITDA Growth Rate %-24.6Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-138.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M156ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NAVBKeeley Asset Management Corp 2015-12-31 Sold Out $1.33 - $2.37
($1.72)
$ 0.93-46%Sold Out0
NAVBKeeley Asset Management Corp 2015-06-30 Buy $1.24 - $1.67
($1.45)
$ 0.93-36%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NAVB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-12-01Sell12,500$1.5-38view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-11-02Sell12,500$1.98-53.03view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-10-01Sell12,500$2.27-59.03view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.88-50.53view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.71-45.61view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.24-25view
Troup Gordon ADirector 2015-05-29Buy10,000$1.31-29.01view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.31-29.01view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.33-30.08view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-41.14view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 

More From Other Websites
ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : September 23, 2016 Sep 23 2016
Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones Sep 22 2016
Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones Sep 22 2016
Navidea’s Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial Sep 16 2016
Navidea’s Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial Sep 16 2016
Navidea to Present at Upcoming Investor Conferences Sep 14 2016
Navidea to Present at Upcoming Investor Conferences Sep 14 2016
ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : September 8, 2016 Sep 08 2016
Navidea Biopharmaceuticals Inc Enters into Letter of Intent with Cardinal Health for the Sale of... Sep 07 2016
Navidea Biopharmaceuticals to Hold Investor Update Call Sep 06 2016
Navidea Biopharmaceuticals to Hold Investor Update Call Sep 06 2016
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of... Sep 06 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 06 2016
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of... Sep 06 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure Aug 31 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Financials Aug 19 2016
Edited Transcript of NAVB earnings conference call or presentation 4-Aug-16 12:30pm GMT Aug 15 2016
ETF’s with exposure to Navidea Biopharmaceuticals, Inc. : August 12, 2016 Aug 12 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Aug 11 2016
Navidea Biopharmaceuticals Announces 2016 Annual Meeting Results Aug 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)